| Cat.No. | Name | Information |
|---|---|---|
| M49456 | ARX-517 | ARX-517 is an antibody-coupled compound (ADC) targeting prostate-specific membrane antigen (PSMA), which can be used in prostate cancer-related studies. |
| M19966 | PSMA-11 | Psma-11 is a positron emission tomography (PET) tracer. Psma-11 detects recurrence and metastasis of prostate cancer by binding to the extracellular region of prostate specific membrane antigen (PSMA). Sequence: Glu - NH - CO - NH - Lys (Ahx) - HBED - CC |
| M9750 | Vipivotide tetraxetan | Vipivotide tetraxetan (PSMA-617) is a potent prostate-specific membrane antigen (PSMA) inhibitor with Ki value of 0.37 nM, it is used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. |
| M56392 | EC1169 | EC1169 is a specific PSMA ligand that inhibits the growth of PSMA-positive cells. |
| M54610 | Glu-urea-Glu-NHS ester | Glu-urea-Glu-NHS ester is an active NHS Glu-urea-Glu that acts as a pharmacophore for binding to prostate-specific membrane antigen (PSMA) inhibitors. |
| M52838 | PSMA-1007 | PSMA-1007 is a prostate-specific membrane antigen (PSMA) ligand. |
| M51088 | PSMA targeting peptide | PSMA-1 is a PSMA targeting peptide (GRFLTGGTGRLLRIS) and can be used for for targeted delivery of glucose-regulated protein (GRP)-silencing siRNAs in PCa cells. |
| M50198 | Pelgifatamab | Pelgifatamab is a monoclonal antibody targeting prostate cancer-specific membrane antigen (PSMA) for prostate cancer-related studies. |
| M25122 | Voxalatamab | Voxalatamab (JNJ-63898081) is a bispecific IgG4 antibody that binds PSMA and CD3 and has anti-cancer activity for use in prostate cancer research. |
| M25063 | Rosopatamab | Rosopatamab (HJ 591) is a humanised anti-PSMA monoclonal antibody that can be used in cancer research, particularly in prostate cancer. |
| M24675 | Pasotuxizumab | Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
